Small-molecule inhibitors of ERK-mediated immediate early gene expression and proliferation of melanoma cells expressing mutated BRaf.

Using virtual screening and biological assays, we have identified and characterized a new class of compounds that selectively inhibit the proliferation of cancer cells containing constitutively active kinase signalling pathways by targeting kinase regulation of oncogenic transcription factors.